Skip to main content
SpringerLink
Log in

Phase II evaluation of bisantrene in refractory multiple myeloma

A Southwest Oncology Group study

  • Clinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yap H, Yap B, Blumenschien GR, Barnes BC, Schell FC, Bodey GP: Bisantrene, an active new drug in the treatment of metastatic breast cancer. Cancer Res 43:1402–1404, 1983

    Google Scholar 

  2. Osborne CK, Von Hoff DD, Cowan JD, Sandbach J: Bisantrene, an active drug in patients with advanced breast cancer. Cancer Treat Rep 68:357–360, 1984

    Google Scholar 

  3. Von Hoff DD, Forseth B, Metelmann H, Harris G, Rowan S, Coltman CA Jr: Direct cloning of human malignant melanoma in soft agar culture. Cancer 50:696–701, 1982

    Google Scholar 

  4. Salmon SE, Meyskens FL Jr, Alberts DS, Soehnlen B, Young L: New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay. Cancer Treat Rep 65:1–2, 1981

    Google Scholar 

  5. Mackel C, Meyskens FL Jr, Alberts DS: Phase II Trial of Bisantrene in Patients with Metastatic Melanoma. Cancer Treat Rep 70:1037–1038, 1986

    Google Scholar 

  6. Durie BGM, Young LA, Salmon SE: Human Myeloma In Vitro Colony Growth: Interrelations Between Drug Sensitivity, Cell Kinetics, Patient Survival Duration. Blood 61:929–934, 1983

    Google Scholar 

  7. Durie BGM, Dixon DO, Carter S, Stephens R, Rivkin S, Bonnet J, Salmon SE, Dabich L, Files JC, Costanzi JJ: Improved Survival Duration With Combination Chemotherapy Induction for Multiple Myeloma. J Clin Onc 4:1227–1237, 1986

    Google Scholar 

  8. Durie BGM: Staging and Kinetics of Multiple Myeloma: Sem Onc 13:300–309, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Arizona Cancer Center, USA

    Brian G. M. Durie

  2. Southwest Oncology Group Statistical Center-Seattle, USA

    John Crowley

  3. University of Texas Health Science Center-San Antonio, USA

    Charles A. Coltman Jr.

  4. Henry Ford Hospital, USA

    Robert A. Chapman

  5. Ohio State University Health Center, USA

    Stanley P. Balcerzk

  6. Scott & White Clinic, USA

    John D. Bonnet

  7. University of Arkansas for Medical Science, USA

    David A. Lipschitz

  8. University of Kansas Medical Center, USA

    Ronald L. Stephens

  9. University of Utah Medical Center, USA

    Bruce D. Cheson

Authors
  1. Brian G. M. Durie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Crowley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles A. Coltman Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert A. Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stanley P. Balcerzk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John D. Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David A. Lipschitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ronald L. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bruce D. Cheson
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Address for offprints: Southwest Oncology Group (SWOG-8108), Operations Office, 5430 Fredericksburg Road, Suite #618, San Antonio, TX 78229, USA

for the Myeloma Committee of the Southwest Oncology Group study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durie, B.G.M., Crowley, J., Coltman, C.A. et al. Phase II evaluation of bisantrene in refractory multiple myeloma. Invest New Drugs 9, 329–331 (1991). https://doi.org/10.1007/BF00183574

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00183574

key words

Search

Navigation